EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 152 filers reported holding EAGLE PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 0.87 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $64,851,000 | -0.4% | 935,398 | +8.7% | 0.65% | +8.0% |
| Q2 2018 | $65,137,000 | +41.6% | 860,911 | -1.4% | 0.60% | +45.8% |
| Q1 2018 | $46,005,000 | -4.5% | 873,131 | -3.2% | 0.41% | +2.0% |
| Q4 2017 | $48,169,000 | -0.8% | 901,697 | +10.7% | 0.40% | -2.4% |
| Q3 2017 | $48,560,000 | -11.4% | 814,214 | +17.2% | 0.42% | -14.4% |
| Q2 2017 | $54,820,000 | -12.5% | 694,887 | -8.0% | 0.48% | -13.9% |
| Q1 2017 | $62,622,000 | +1891.2% | 755,027 | +1804.5% | 0.56% | +1841.4% |
| Q4 2016 | $3,145,000 | +65.5% | 39,645 | +46.0% | 0.03% | +70.6% |
| Q3 2016 | $1,900,000 | +138.1% | 27,145 | +32.0% | 0.02% | +142.9% |
| Q2 2016 | $798,000 | – | 20,565 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Park West Asset Management LLC | 1,120,235 | $53,749,000 | 2.66% |
| TANG CAPITAL MANAGEMENT LLC | 255,616 | $12,264,000 | 1.19% |
| Smith, Graham & Co., Investment Advisors, LP | 158,671 | $7,613,000 | 0.92% |
| ARMISTICE CAPITAL, LLC | 282,000 | $13,530,000 | 0.59% |
| Capital Impact Advisors, LLC | 35,815 | $1,718,000 | 0.57% |
| Matarin Capital Management, LLC | 58,977 | $2,830,000 | 0.56% |
| GLOBEFLEX CAPITAL L P | 31,702 | $1,521,000 | 0.39% |
| CHARTWELL INVESTMENT PARTNERS, LLC | 200,246 | $9,608,000 | 0.37% |
| Stanley-Laman Group, Ltd. | 24,000 | $1,152,000 | 0.28% |
| VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. | 264 | $13,000 | 0.20% |